The tuberculosis treatment success rate for previously treated cases in the US is forecasted to remain stable at 78% from 2024 to 2028. This stability follows the 2023 success rate, suggesting no year-on-year growth or decline in the upcoming years, thereby indicating a consistent level of treatment efficacy.
Future trends to watch for include advancements in medical treatments and technologies, potential changes in healthcare policies, efforts to improve patient adherence, and the development of newer TB drugs. These factors could influence treatment success rates, requiring ongoing monitoring and analysis.
